Industry and News Large Volume Parenteral Market | Page 2

the plastic and even some drugs and solutions percolate into plastics removing the plasticizer.
Plasticizer helps in keeping the plastic flexible. With some alternatives and modifications there are
now newer plastics that eliminate such discrepancies. On a commercial scale, plastic bags are
accessible in different sizes. There are many various LVP solutions available commercially and with
various solutions.
The key driving factors responsible for the growth of Large Volume Parenteral Market include
growing demand for LVP preparations and constantly rise in number of surgeries and a rising rate of
hospitalization are considered to fuel the market growth for the forecast period. Additionally,
growing demands for reliable and most effective modes of drug administration in patients have also
propelled the market growth for the forecast period. Moreover, growth in consumer acceptance for
single dosage vaccines and drugs for central nervous system is likely to drive market demand for the
forecast period.
On the basis of category, the global large volume parenteral market is segmented into nutritious
injections, therapeutic injections and injections. On the basis of drugs, the global large volume
parenteral market is segmented into vaccines, anti-infective drugs, oncology drugs, diabetes drugs
and gastrointestinal drugs. On the basis of type, the global market is segmented into carbohydrates,
electrolytes, irrigating solutions, nutritional solutions and peritoneal dialysis solutions. On the basis
of route of administration, the global large volume parenteral market is segmented into
intradermal, intraspinal, intramuscular, intra-arterial, intravenous and subcutaneous.
Request Sample Copy of this Market Research @
https://www.millioninsights.com/industry-reports/large-volume-parenteral-lvp-market/request-sample
On the basis of geographic segmentation, the global LVP industry spans North America, Latin
America, Europe, Asia-Pacific, and Middle-East & Africa. North America is anticipated to grow at a
higher CAGR during the forecast period. APAC regions are expected to rise at a higher CAGR owing
to larger consumer base and rising geriatric population. Middle-East and African regions are
anticipated to grow at a moderate CAGR due to rising medical infrastructure in these regions.
The key players in the global large volume parenteral market include Baxter Healthcare Corporation,
Kelun Pharma, BAG Healthcare GmbH, Patheon Inc., Hospira, Inc., Otsuka Pharmaceutical,